Cholesterol 2001: Rationale for lipid-lowering in older patients with or without CAD

Geriatrics

Volumn 56, Issue 9, 2001, Pages 22-30

  Aronow, W S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTERY DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; ELDERLY CARE; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; INTERMITTENT CLAUDICATION; LIPID BLOOD LEVEL; META ANALYSIS; MORTALITY; REVIEW; RISK FACTOR; STROKE;

AGED; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PRACTICE GUIDELINES; RISK FACTORS; VASCULAR DISEASES;

EID: 0034809501     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Summary of the second report of the National Cholesterol Education Program (NCEP)
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
3. Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease
4. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study (4S)
5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
6. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
7. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial
8. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
9. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial
10. Effect of lipid-lowering on early mortality after acute coronary syndromes: An observational study
11. Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: Observations from OPUSTIMI 16
12. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations
13. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
14. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial
15. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women 62 years of age
16. Prognostic significance of silent ischemia in elderly patients with peripheral arterial disease with and without previous myocardial infarction
17. Forty-five-month follow-up of extracranial carotid arterial disease for new coronary events in elderly patients
18. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials
19. Risk factors for extracranial internal or common carotid arterial disease in elderly patients
20. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)
21. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
22. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS
23. Air Force/Texas Coronary Atherosclerosis Prevention study: Extending the benefit of primary prevention to healthy elderly men and women
24. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol >125 mg/dl
25. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)